Equillium's itolizumab showed improved longer-term outcomes in aGVHD despite missing primary endpoints. FDA feedback on ...
US biotech Equillium reported Thursday that its lead drug candidate itolizumab failed to meet the main objective in a Phase ...
Buffalo Trace has become the most popular distillery in America since the bourbon boom, but is that popularity warranted? We ...
12hOpinion
ARTnews on MSNDealer Vs. Gallerist: A PrimerApple's new TV series is called "The Dealer," and a new movie is called The Gallerist. So, what is the difference between a ...
Heres the comparison of both the Infinix Note 50x and Realme P3, which will help you pick the right one based on your needs.
Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® (normal immunoglobulin [human] 10% and recombinant human hyaluronidase ...
The MacBook Pro's entry-level version features an Apple M4 chip with a 10-core CPU and a 10-core GPU. Aside from the ...
4h
GOBankingRates on MSNShare Certificate vs. CD: Which Offers Better Returns?Discover the differences between a share certificate vs. CD and find out why each investment option offers a unique blend of ...
In the almost seven years since the additional roles reimbursement scheme (ARRS) was introduced there has been a dramatic ...
The UK Debt Management Office's financing programme for 2025-26 will be its second biggest ever, and to handle it, the DMO ...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results